Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.
We report that 11 human immunodeficiency virus 1 (HIV-1)-seropositive patients, including three AIDS patients, were able to generate a cellular immune response to the intradermal injection of low doses (2-10 micrograms) of recombinant interleukin 2 (rIL-2). A dose-dependent zone of induration appear...
Kaydedildi:
| Yayımlandı: | Proc Natl Acad Sci U S A |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
National Academy of Sciences
1990
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC54412/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2143021/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.87.15.5783 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|